TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of General Internal Medicine
Division of Infectious Disease
更新時間：2024-03-26
謝思民Hsieh, Szu-Min
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
-
doceason1967@gmail.com
Publication
39Publications
11
Liu CH, Liu CJ, Hung CC, Hsieh SM, Su TH, Sun HY, Tseng TC, Chen PJ, Chen DS, Kao JH. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan. Liver Int. 2020 Apr;40(4):758-768. doi: 10.1111/liv.14295. Epub 2019 Nov 11. PMID: 31710759.
12
Liu CH, Sun HY, Hsieh SM, Liu WC, Sheng WH, Liu CJ, Su TH, Tseng TC, Chen PJ, Hung CC, Kao JH. Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy. J Viral Hepat. 2021 Jun;28(6):887-896. doi: 10.1111/jvh.13502. Epub 2021 Apr 3. PMID: 33759290.
13
Liu WD, Hung CC, Wang JT, Tsai MJ, Kuo PH, Chao TL, Hsieh SM, Sheng WH, Chen YC, Chang SY, Chang SC. Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19. J Formos Med Assoc. 2021 Dec;120(12):2186-2190. doi: 10.1016/j.jfma.2021.04.010. Epub 2021 Apr 21. PMID: 33933336; PMCID: PMC8059939.
14
Liu WD, Tsai WC, Hsu WT, Shih MC, Chen MY, Sun HY, Hsieh SM, Sheng WH, Chuang YC, Cheng A, Lin KY, Huang YS, Huang SH, Huang YC, Chen GJ, Wu PY, Hung CC, Chang SC. Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan. J Microbiol Immunol Infect. 2020 Dec;53(6):936-945. doi: 10.1016/j.jmii.2019.03.008. Epub 2019 May 7. PMID: 31105037.
15
Pan SC, Hsieh SM, Lin CF, Hsu YS, Chang M, Chang SC. A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(αK): A phase I study. Vaccine. 2019 Mar 28;37(14):1994-2003. doi: 10.1016/j.vaccine.2019.02.006. Epub 2019 Mar 2. PMID: 30837170.
16
Pan SC, Hsu WT, Lee WS, Wang NC, Chen TJ, Liu MC, Pai HC, Hsu YS, Chang M, Hsieh SM. A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study. Vaccine. 2020 Jan 29;38(5):1048-1056. doi: 10.1016/j.vaccine.2019.11.047. Epub 2019 Dec 4. PMID: 31812463.
17
Pan SC, Huang YS, Hsieh SM, Chen YC, Chang SY, Chang SC. A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan. J Formos Med Assoc. 2021 Jul;120(7):1459-1463. doi: 10.1016/j.jfma.2021.01.002. Epub 2021 Jan 9. PMID: 33461841; PMCID: PMC7833685.
18
Tsai MJ, Sun HY, Hsieh SM, Sheng WH, Chuang YC, Huang YS, Huang SH, Su LH, Su YC, Liu WC, Chang SY, Hung CC. Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014-2018. J Microbiol Immunol Infect. 2021 Oct;54(5):934-943. doi: 10.1016/j.jmii.2020.11.005. Epub 2020 Dec 9. PMID: 33349600.
19
Tsai WC, Hsu WT, Liu WD, Sun HY, Chuang YC, Huang YS, Cheng A, Lin KY, Huang YC, Chen GJ, Huang SH, Sheng WH, Hsieh SM, Hung CC, Chang SC. Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection. Liver Int. 2019 Aug;39(8):1408-1417. doi: 10.1111/liv.14059. Epub 2019 Feb 17. PMID: 30712284.
20
Wu PY, Chen MY, Sheng WH, Hsieh SM, Chuang YC, Cheng A, Pan SC, Wu UI, Chang HY, Luo YZ, Yang SP, Zhang JY, Sun HY, Hung CC. Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan. J Microbiol Immunol Infect. 2019 Aug;52(4):549-555. doi: 10.1016/j.jmii.2019.03.006. Epub 2019 Apr 11. PMID: 31036484.
